NZ334448A - olanzapine dihydrate which can be used in a process for preparing olanzapine - Google Patents

olanzapine dihydrate which can be used in a process for preparing olanzapine

Info

Publication number
NZ334448A
NZ334448A NZ334448A NZ33444897A NZ334448A NZ 334448 A NZ334448 A NZ 334448A NZ 334448 A NZ334448 A NZ 334448A NZ 33444897 A NZ33444897 A NZ 33444897A NZ 334448 A NZ334448 A NZ 334448A
Authority
NZ
New Zealand
Prior art keywords
dihydrate
olanzapine
compound
pct
mimosa
Prior art date
Application number
NZ334448A
Other languages
English (en)
Inventor
Charles A Bunnell
Samuel D Larsen
John R Nichols
Susan M Reutzel
Gregory A Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ334448(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ334448A publication Critical patent/NZ334448A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ334448A 1996-09-23 1997-09-18 olanzapine dihydrate which can be used in a process for preparing olanzapine NZ334448A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23
PCT/US1997/016499 WO1998012199A1 (en) 1996-09-23 1997-09-18 Intermediates and process for preparing olanzapine

Publications (1)

Publication Number Publication Date
NZ334448A true NZ334448A (en) 2000-08-25

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ334448A NZ334448A (en) 1996-09-23 1997-09-18 olanzapine dihydrate which can be used in a process for preparing olanzapine

Country Status (35)

Country Link
US (1) US6020487A (cg-RX-API-DMAC7.html)
EP (1) EP0831098B1 (cg-RX-API-DMAC7.html)
JP (2) JP2001500877A (cg-RX-API-DMAC7.html)
KR (1) KR100560015B1 (cg-RX-API-DMAC7.html)
CN (1) CN1122036C (cg-RX-API-DMAC7.html)
AR (1) AR013838A1 (cg-RX-API-DMAC7.html)
AT (1) ATE209208T1 (cg-RX-API-DMAC7.html)
AU (1) AU719441B2 (cg-RX-API-DMAC7.html)
BR (1) BR9712100A (cg-RX-API-DMAC7.html)
CA (1) CA2265712C (cg-RX-API-DMAC7.html)
CO (1) CO4910140A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ299248B6 (cg-RX-API-DMAC7.html)
DE (1) DE69708428T2 (cg-RX-API-DMAC7.html)
DK (1) DK0831098T3 (cg-RX-API-DMAC7.html)
EA (1) EA001642B1 (cg-RX-API-DMAC7.html)
EG (1) EG23861A (cg-RX-API-DMAC7.html)
ES (1) ES2166051T3 (cg-RX-API-DMAC7.html)
HU (1) HU226484B1 (cg-RX-API-DMAC7.html)
ID (1) ID27275A (cg-RX-API-DMAC7.html)
IL (1) IL128962A (cg-RX-API-DMAC7.html)
IN (1) IN187156B (cg-RX-API-DMAC7.html)
MY (1) MY125565A (cg-RX-API-DMAC7.html)
NO (1) NO323980B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ334448A (cg-RX-API-DMAC7.html)
PE (1) PE110398A1 (cg-RX-API-DMAC7.html)
PL (3) PL196069B1 (cg-RX-API-DMAC7.html)
PT (1) PT831098E (cg-RX-API-DMAC7.html)
RS (1) RS49598B (cg-RX-API-DMAC7.html)
SI (1) SI0831098T1 (cg-RX-API-DMAC7.html)
SV (1) SV1997000081A (cg-RX-API-DMAC7.html)
TR (1) TR199900640T2 (cg-RX-API-DMAC7.html)
TW (1) TW470746B (cg-RX-API-DMAC7.html)
UA (1) UA59371C2 (cg-RX-API-DMAC7.html)
WO (1) WO1998012199A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA978515B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004507548A (ja) * 2000-08-31 2004-03-11 ドクター・レディーズ・ラボラトリーズ・リミテッド オランザピン水和物の調製方法、及びこれを結晶形態のオランザピンに変換する方法
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
AU2002340328A1 (en) * 2001-10-29 2003-05-12 Janet I. Cord Olanzapine dihydrate-ii a process for its preparation and use thereof
CH695862A5 (fr) 2001-12-24 2006-09-29 Sun Pharmaceutical Ind Ltd Forme cristalline I de la methyl-4-(4-methyl-1-piperazinyl) 10H-thieno [2,3-b] [1,5] benzodiazepine.
WO2003091260A1 (en) * 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
ATE500258T1 (de) 2002-05-31 2011-03-15 Sandoz Ag Verfahren zur herstellung von olanzapin form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
JP2007511605A (ja) * 2003-11-18 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー オランザピン含有経皮薬物送達組成物
PL1611139T3 (pl) * 2003-12-22 2008-10-31 Teva Pharma Sposób wytwarzania olenzapiny
EP1709053B1 (en) 2004-01-27 2011-04-06 Synthon B.V. Stable salts of olanzapine
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
WO2006006185A1 (en) * 2004-07-14 2006-01-19 Shasun Chemicals And Drugs Limited Improved process for making form i of olanzapine.
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
WO2006027800A1 (en) * 2004-09-06 2006-03-16 Shasun Chemicals And Drugs Limited A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine
CA2587710C (en) * 2004-11-16 2014-10-21 Elan Pharma International Ltd. Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
TW268005B (cg-RX-API-DMAC7.html) * 1992-05-29 1996-01-11 Lilly Industries Ltd
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
PL194074B1 (pl) * 1996-09-23 2007-04-30 Lilly Co Eli Polimorf Dihydrat D olanzapiny i preparat farmaceutyczny zawierający Dihydrat D olanzapiny

Also Published As

Publication number Publication date
PT831098E (pt) 2002-04-29
WO1998012199A1 (en) 1998-03-26
PL196068B1 (pl) 2007-12-31
IL128962A (en) 2003-01-12
ZA978515B (en) 1999-03-23
TR199900640T2 (xx) 1999-06-21
HUP0000066A3 (en) 2000-11-28
UA59371C2 (uk) 2003-09-15
EP0831098A2 (en) 1998-03-25
DK0831098T3 (da) 2002-05-21
HU226484B1 (en) 2009-03-02
AU719441B2 (en) 2000-05-11
CA2265712A1 (en) 1998-03-26
CZ299248B6 (cs) 2008-05-28
YU15599A (sh) 2001-12-26
JP2001500877A (ja) 2001-01-23
EA199900326A1 (ru) 1999-08-26
CZ99099A3 (cs) 1999-11-17
SV1997000081A (es) 1999-01-14
HK1009807A1 (en) 1999-06-11
ES2166051T3 (es) 2002-04-01
NO991382D0 (no) 1999-03-22
CA2265712C (en) 2006-10-31
EP0831098B1 (en) 2001-11-21
AR013838A1 (es) 2001-01-31
ATE209208T1 (de) 2001-12-15
PL194565B1 (pl) 2007-06-29
AU4484197A (en) 1998-04-14
NO991382L (no) 1999-03-22
HUP0000066A2 (hu) 2000-06-28
JP2009242407A (ja) 2009-10-22
US6020487A (en) 2000-02-01
MY125565A (en) 2006-08-30
ID27275A (id) 2001-03-22
BR9712100A (pt) 1999-08-31
NO323980B1 (no) 2007-07-30
DE69708428T2 (de) 2002-07-04
CN1122036C (zh) 2003-09-24
TW470746B (en) 2002-01-01
IN187156B (cg-RX-API-DMAC7.html) 2002-02-16
SI0831098T1 (en) 2002-04-30
PL196069B1 (pl) 2007-12-31
EG23861A (en) 2007-11-18
PE110398A1 (es) 1999-01-14
CN1234802A (zh) 1999-11-10
DE69708428D1 (de) 2002-01-03
KR20000048520A (ko) 2000-07-25
IL128962A0 (en) 2000-02-17
KR100560015B1 (ko) 2006-03-15
CO4910140A1 (es) 2000-04-24
PL332482A1 (en) 1999-09-13
RS49598B (sr) 2007-06-04
EP0831098A3 (en) 1998-04-29
EA001642B1 (ru) 2001-06-25

Similar Documents

Publication Publication Date Title
NZ334448A (en) olanzapine dihydrate which can be used in a process for preparing olanzapine
AP828A (en) Process and crystal forms of 2-methyl-thieno-benzodiazepine.
WO2016015653A1 (zh) C-Met抑制剂结晶型游离碱或其结晶型酸式盐及其制备方法和应用
CA2493370C (en) Crystal forms of olanzapine and processes for their preparation
CA2395774C (en) New polymorphic forms of olanzapine
HK1009807B (en) Intermediates and process for preparing olanzapine
MXPA97007183A (en) A process and glass forms of 2-methyl-tieno-benzodiazep

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LCEA Licensees added

Name of requester: ELI LILLY AND COMPANY (NZ) LIMITED

RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired